<Version>
  <xmlSource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Quality Measures Clearinghouse (NQMC).</xmlSource>
  <Section SecID="560" OrdBy="10" Name="General">
    <Field FieldID="11" OrdBy="20" ID="561" Name="Title" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Sepsis: median time to initiation of Vancomycin (or Linezolid) following severe sepsis/septic shock identification.&lt;/div&gt;" />
    </Field>
    <Field FieldID="1" OrdBy="30" ID="562" Name="Source(s)" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;VHA, Inc. Transformation of the intensive care unit: sepsis data collection toolkit. Irving (TX): VHA, Inc.; 2007 Jan 1. 29 p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
  </Section>
  <Section SecID="563" OrdBy="40" Name="Measure Domain">
    <Field FieldID="3025" OrdBy="50" ID="564" Name="Primary Measure Domain" Type="picklist-one">
      <FieldValue Value="Clinical Quality Measures: Process" />
    </Field>
    <Field FieldID="3026" OrdBy="60" ID="565" Name="Secondary Measure Domain" Type="picklist-one">
      <FieldValue Value="Does not apply to this measure" />
    </Field>
  </Section>
  <Section SecID="566" OrdBy="70" Name="Brief Abstract">
    <Field FieldID="34" OrdBy="80" ID="567" Name="Description" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This measure is used to assess the median time to initiation of Vancomycin (or Linezolid) following severe sepsis/septic shock identification.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="21" OrdBy="90" ID="568" Name="Rationale" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Studies show that annually there are between 500,000 to one million cases of sepsis and severe sepsis in American hospitals. The annual mortality rate for these cases is between 15 and 30 percent or as many as 200,000 deaths. Many more patients suffer from permanent organ damage. The cost to society in dollars spent and lives lost prematurely is enormous. While there are many useful clinical interventions, research shows that they are applied inconsistently, if at all.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;There is emerging evidence that the sickest patients should be treated with broad-spectrum antibiotics as soon as possible. This approach contrasts with treatment for less sick patients where, in general, we start with a narrow-spectrum antibiotic and broaden antibiotics if the patient does not respond.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;With critically ill patients (those with severe sepsis or septic shock), clinicians cannot afford to under treat. Evidence suggests that the initial use of inadequate antibiotics nearly doubles the patients' mortality. As a result, the approach to antibiotic management in patients with severe sepsis or septic shock should be to start broad as soon as possible until culture results are available and the regimen can be narrowed.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Just what constitutes adequate broad-spectrum antibiotic coverage is an ongoing controversy. Because pseudomonas is a common pathogen, the initial antibiotic therapy should include a medication against pseudomonas. Increasingly, methicillin-resistant staph aureus (MRSA) is a cause of infection and one of the most common reasons for inadequate antibiotic therapy. In addition, a recent study suggests that 12 percent of MRSA infections were community-acquired and these patients lacked established risk factors. Because our ability to predict who is at risk for pseudomonas and MRSA is imprecise and because a patient's mortality nearly doubles if infections with these organisms go untreated with the initial antibiotics, we recommend that unless the clinician is confident that the probability of pseudomonas or MRSA is zero, an antibiotic to treat pseudomonas and MRSA should be included in the initial antibiotic therapy for critically ill patients.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The potential downside of this strategy is enhanced antibiotic resistance. Though the data is limited, most experts believe that four days of antibiotics is unlikely to cause resistance. Resistance ensues when the drugs are continued for long periods of time. Among critically ill patients, the risk-benefit ratio thus strongly favors starting broad-spectrum antibiotics that includes anti-pseudomonal and MRSA drugs. These antibiotics should be discontinued if not needed when culture results are available.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3500" OrdBy="100" ID="569" Name="Evidence for Rationale" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003 Apr 17;348(16):1546-54. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12700374&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O'Boyle C, Danila RN, Lynfield R. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003 Dec 10;290(22):2976-84. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14665659&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;VHA, Inc. Improving sepsis care in the intensive care unit: an evidence-based approach. Irving (TX): VHA, Inc.; 2004. 60 p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
    <Field FieldID="3022" OrdBy="110" ID="570" Name="Primary Health Components" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Severe sepsis; septic shock; Vancomycin (or Linezolid); median time to initiation&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="23" OrdBy="120" ID="571" Name="Denominator Description" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Patients, 16 years of age and older, with a diagnosis of severe sepsis/septic shock (see the related &quot;Denominator Inclusions/Exclusions&quot; field)&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="24" OrdBy="130" ID="572" Name="Numerator Description" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Continuous variable statement&lt;/em&gt;: Median time, in hours, from severe sepsis/septic shock identification to the initiation of Vancomycin (or Linezolid) for patients with severe sepsis/septic shock&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="573" OrdBy="140" Name="Evidence Supporting the Measure">
    <Field FieldID="3027" OrdBy="150" ID="574" Name="Type of Evidence Supporting the Criterion of Quality for the Measure" Type="picklist-choice">
      <FieldValue Value="One or more research studies published in a National Library of Medicine (NLM) indexed, peer-reviewed journal" />
    </Field>
    <Field FieldID="3501" OrdBy="160" ID="575" Name="Additional Information Supporting Need for the Measure" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A study confirmed that patients with severe sepsis consume significant resources. The average hospital length of stay was 20 days at an average cost of $22,100. National cost estimates for the care of severe sepsis based on this study is $16.7 billion dollars, with the care of patients older than 65 costing $8.7 billion (52.3 percent), and care of those older than 75 costs $5.1 billion dollars (30.8 percent). The costs for caring for patients with sepsis are projected to rise approximately 1.5 percent per year due to the aging U.S. population.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3502" OrdBy="170" ID="576" Name="Evidence for Additional Information Supporting Need for the Measure" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;VHA, Inc. Improving sepsis care in the intensive care unit: an evidence-based approach. Irving (TX): VHA, Inc.; 2004. 60 p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
    <Field FieldID="3072" OrdBy="180" ID="577" Name="Extent of Measure Testing" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="580" OrdBy="210" Name="State of Use of the Measure">
    <Field FieldID="3029" OrdBy="220" ID="581" Name="State of Use" Type="picklist-one">
      <FieldValue Value="Current routine use" />
    </Field>
    <Field FieldID="3030" OrdBy="230" ID="582" Name="Current Use" Type="picklist-choice-3">
      <FieldValue Value="not defined yet" />
    </Field>
  </Section>
  <Section SecID="583" OrdBy="240" Name="Application of the Measure in its Current Use">
    <Field FieldID="3031" OrdBy="250" ID="584" Name="Measurement Setting" Type="picklist-choice">
      <FieldValue Value="Hospital Inpatient" />
      <FieldValue Value="Intensive Care Units" />
    </Field>
    <Field FieldID="3032" OrdBy="260" ID="585" Name="Professionals Involved in Delivery of Health Services" Type="picklist-choice-3">
      <FieldValue Value="not defined yet" />
    </Field>
    <Field FieldID="3033" OrdBy="270" ID="586" Name="Least Aggregated Level of Services Delivery Addressed" Type="picklist-one">
      <FieldValue Value="Single Health Care Delivery or Public Health Organizations" />
    </Field>
    <Field FieldID="3505" OrdBy="280" ID="587" Name="Statement of Acceptable Minimum Sample Size" Type="picklist-one">
      <FieldValue Value="Unspecified" />
    </Field>
    <Field FieldID="41" OrdBy="290" ID="588" Name="Target Population Age" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Age greater than or equal to 16 years&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="42" OrdBy="300" ID="589" Name="Target Population Gender" Type="picklist-one">
      <FieldValue Value="Either male or female" />
    </Field>
  </Section>
  <Section SecID="660" OrdBy="310" Name="National Strategy for Quality Improvement in Health Care">
    <Field FieldID="3522" OrdBy="320" ID="661" Name="National Quality Strategy Aim" Type="text">
      <FieldValue Value="&lt;ul&gt;&lt;li&gt;Better Care&lt;/li&gt;&lt;/ul&gt;" />
    </Field>
    <Field FieldID="3525" OrdBy="330" ID="662" Name="National Quality Strategy Priority" Type="text">
      <FieldValue Value="&lt;ul&gt;&lt;li&gt;Prevention and Treatment of Leading Causes of Mortality&lt;/li&gt;&lt;/ul&gt;" />
    </Field>
  </Section>
  <Section SecID="590" OrdBy="340" Name="Institute of Medicine (IOM) National Health Care Quality Report Categories">
    <Field FieldID="3163" OrdBy="350" ID="591" Name="IOM Care Need" Type="picklist-choice">
      <FieldValue Value="Getting Better" />
    </Field>
    <Field FieldID="3164" OrdBy="360" ID="592" Name="IOM Domain" Type="picklist-choice">
      <FieldValue Value="Effectiveness" />
    </Field>
  </Section>
  <Section SecID="593" OrdBy="370" Name="Data Collection for the Measure">
    <Field FieldID="3506" OrdBy="380" ID="594" Name="Case Finding Period" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3054" OrdBy="390" ID="595" Name="Denominator Sampling Frame" Type="picklist-one">
      <FieldValue Value="Patients associated with provider" />
    </Field>
    <Field FieldID="3057" OrdBy="400" ID="598" Name="Denominator (Index) Event or Characteristic" Type="picklist-choice">
      <FieldValue Value="Clinical Condition" />
      <FieldValue Value="Institutionalization" />
      <FieldValue Value="Patient/Individual (Consumer) Characteristic" />
    </Field>
    <Field FieldID="3058" OrdBy="410" ID="599" Name="Denominator Time Window" Type="picklist-choice-3">
      <FieldValue Value="not defined yet" />
    </Field>
    <Field FieldID="55" OrdBy="420" ID="596" Name="Denominator Inclusions/Exclusions" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Inclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Patients, 16 years of age and older, with a diagnosis of severe sepsis/septic shock&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Exclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Any one of the following:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Patients less than 16 years of age &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patients with renal failure &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Not Applicable because:&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;An organism (other than methicillin-resistant Staphylococcus aureus [MRSA] or methicillin-resistant Staphylococcus epidermidis [MRSE]) responsible for sepsis has been identified &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Patient had severe allergies to Vancomycin and Linezolid &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Had contraindications/reasons for not receiving Vancomycin and Linezolid &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Was diagnosed with secondary bacterial peritonitis &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Care was withdrawn or patient expired within 24 hours following severe sepsis/septic shock identification &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&quot;Not Administered&quot; was selected for Vancomycin (or Linezolid) administration &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Date or Time of severe sepsis/septic shock identification unknown &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Date or Time of Vancomycin (or Linezolid) administration unknown &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;If the option 'All Cases' is selected on report parameter page: Exclude Cases with a time elapsed EARLIER THAN -24 hours or GREATER THAN +72 hours &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;If the option 'Only cases with Vancomycin (or Linezolid) initiated after sepsis identification' is selected on report parameter page: Exclude Cases with a time elapsed EARLIER THAN zero hours or GREATER THAN +72 hours. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Refer to original measure documentation for definitions and additional details.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3507" OrdBy="430" ID="597" Name="Exclusions/Exceptions" Type="picklist-choice-4">
      <FieldValue Value="not defined yet" />
    </Field>
    <Field FieldID="59" OrdBy="440" ID="600" Name="Numerator Inclusions/Exclusions" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Inclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;&lt;em&gt;Continuous variable statement&lt;/em&gt;: Median time, in hours, from severe sepsis/septic shock identification to the initiation of Vancomycin (or Linezolid) for patients with severe sepsis or septic shock&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Exclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3061" OrdBy="450" ID="601" Name="Numerator Search Strategy" Type="picklist-one">
      <FieldValue Value="Institutionalization" />
    </Field>
    <Field FieldID="3062" OrdBy="460" ID="602" Name="Data Source" Type="picklist-many">
      <FieldValue Value="Paper medical record" />
    </Field>
    <Field FieldID="3065" OrdBy="470" ID="603" Name="Type of Health State" Type="picklist-one">
      <FieldValue Value="Does not apply to this measure" />
    </Field>
    <Field FieldID="3066" OrdBy="480" ID="604" Name="Instruments Used and/or Associated with the Measure" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="605" OrdBy="490" Name="Computation of the Measure">
    <Field FieldID="3508" OrdBy="500" ID="606" Name="Measure Specifies Disaggregation" Type="picklist-one">
      <FieldValue Value="Does not apply to this measure" />
    </Field>
    <Field FieldID="3067" OrdBy="520" ID="608" Name="Scoring" Type="picklist-many">
      <FieldValue Value="Mean/Median" />
    </Field>
    <Field FieldID="3068" OrdBy="530" ID="609" Name="Interpretation of Score" Type="picklist-one">
      <FieldValue Value="Desired value is a lower score" />
    </Field>
    <Field FieldID="3090" OrdBy="540" ID="610" Name="Allowance for Patient or Population Factors" Type="picklist-choice-3">
      <FieldValue Value="not defined yet" />
    </Field>
    <Field FieldID="3070" OrdBy="560" ID="612" Name="Standard of Comparison" Type="picklist-choice-3">
      <FieldValue Value="not defined yet" />
    </Field>
  </Section>
  <Section SecID="615" OrdBy="590" Name="Identifying Information">
    <Field FieldID="73" OrdBy="600" ID="616" Name="Original Title" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Median time to Vancomycin (or Linezolid) initiation.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="74" OrdBy="610" ID="617" Name="Measure Collection Name" Type="text">
      <FieldValue Value="Transformation of the Intensive Care Unit (TICU) Measures" />
    </Field>
    <Field FieldID="75" OrdBy="620" ID="618" Name="Measure Set Name" Type="text">
      <FieldValue Value="Sepsis Quality Indicators" />
    </Field>
    <Field FieldID="16" OrdBy="650" ID="621" Name="Submitter" Type="orglist">
      <FieldValue Value="Vizient, Inc. - For Profit Organization" />
    </Field>
    <Field FieldID="17" OrdBy="660" ID="622" Name="Developer" Type="orglist-p">
      <FieldValue Value="Vizient, Inc. - For Profit Organization" />
    </Field>
    <Field FieldID="79" OrdBy="670" ID="623" Name="Funding Source(s)" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;VHA, Inc.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="80" OrdBy="680" ID="624" Name="Composition of the Group that Developed the Measure" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Internal VHA, Inc. clinical subject matter experts along with external clinical subject matter faculty experts from various National and local research medical centers/hospitals&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="81" OrdBy="690" ID="625" Name="Financial Disclosures/Other Potential Conflicts of Interest" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None; work was not supported by any third party vendors, contractors or for-profit health care companies including suppliers, device makers, or pharmaceutical firms.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="19" OrdBy="730" ID="629" Name="Adaptation" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This measure was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3086" OrdBy="740" ID="630" Name="Date of Most Current Version in NQMC" Type="date">
      <FieldValue Value="2007 Jan" />
    </Field>
    <Field FieldID="3511" OrdBy="750" ID="631" Name="Measure Maintenance" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="3512" OrdBy="760" ID="632" Name="Date of Next Anticipated Revision" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="20" OrdBy="770" ID="633" Name="Measure Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the measure.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The measure developer reaffirmed the currency of this measure in November 2015.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="14" OrdBy="780" ID="634" Name="Measure Availability" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Source not available electronically.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For more information, contact VHA, Inc. at: 220 E. Las Colinas Blvd., Irving, TX 75039; Phone: 1-800-842-5146 or 1-972-830-0626; Web site: &lt;a href=&quot;http://www.vha.com&quot; title=&quot;VHA, Inc. Web site&quot;&gt;www.vha.com&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="15" OrdBy="790" ID="635" Name="Companion Documents" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following is available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;VHA, Inc. Improving Sepsis Care in the Intensive Care Unit: An Evidence-Based Approach. Irving (TX): VHA, Inc.; 2004. 60 p. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;For more information, contact VHA, Inc. at: 220 E. Las Colinas Blvd., Irving, TX 75039; Phone: 1-800-842-5146 or 1-972-830-0626; Web site: &lt;a href=&quot;http://www.vha.com&quot; title=&quot;VHA, Inc. Web site&quot;&gt;www.vha.com&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="87" OrdBy="800" ID="636" Name="NQMC Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NQMC summary was completed by ECRI Institute on September 23, 2008. The information was verified by the measure developer on November 13, 2008. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;This NQMC summary was retrofitted into the new template on May 12, 2011. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;The information was reaffirmed by the measure developer on November 10, 2015.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="88" OrdBy="810" ID="637" Name="Copyright Statement" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NQMC summary is based on the original measure, which is subject to the measure developer's copyright restrictions.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="641" OrdBy="850" Name="Production">
    <Field FieldID="1" OrdBy="1366" ID="562" Name="Source(s)" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;VHA, Inc. Transformation of the intensive care unit: sepsis data collection toolkit. Irving (TX): VHA, Inc.; 2007 Jan 1. 29 p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
  </Section>
  <Section SecID="99999" OrdBy="99999" Name="Disclaimer">
    <Field FieldID="99999" OrdBy="99999" ID="99999" Name="NQMC Disclaimer" Type="text">
      <FieldValue Value="&lt;p&gt;The National Quality Measures Clearinghouseâ„¢ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the &lt;a href=&quot;/help-and-about/summaries/inclusion-criteria&quot;&gt;NQMC Inclusion Criteria&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding measure content are directed to contact the measure developer.&lt;/p&gt;" />
    </Field>
  </Section>
</Version>